Iterative LC-MS/MS for Low-Abundance HCP Quantitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying and quantitating host cell proteins (HCPs) in therapeutic protein development face challenges in achieving robust, unbiased, and sensitive analysis, particularly due to the high dynamic range of protein abundances and limitations in LC-MS/MS methodologies.
Innovation Solution
The implementation of an automated precursor ion exclusion (PIE) acquisition method, termed HCP-Automated Iterative MS or HCP-AIMS, which uses direct digestion samples without enrichment, performs iterative tandem mass spectrometry analysis, and employs customizable mass and retention time tolerances to enhance the identification and quantitation of low-abundance HCPs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional data-dependent acquisition (DDA) methods are used for HCP identification, then fast and unbiased HCP identification can be achieved, but in-depth and sensitive protein identification or accurate protein quantitation is compromised
Solution Approach 1:
The mass spectrum scan is segmented into multiple iterations where different precursor ions are selected and excluded in successive cycles. This segmentation allows the system to divide the complex task of analyzing all precursors into manageable iterations, progressively building a comprehensive exclusion set that improves both identification depth and quantitation accuracy without sacrificing overall speed.
Solution Approach 2:
The method performs preliminary action by pre-selecting and excluding high-abundance precursor ions in early iterations before they can dominate the analysis. This preliminary exclusion of dominant signals prepares the system to detect and quantify low-abundance HCPs more effectively in subsequent iterations, resolving the contradiction between speed and precision.
2Measurement precision
If enrichment methods are used for low-abundance HCP detection, then detection sensitivity is improved, but analysis time and process complexity increase
Solution Approach 1:
The method extracts or removes high-abundance precursor ions from consideration by adding them to an exclusion set. This extraction of dominant signals from the analytical process allows low-abundance HCPs to be detected directly without requiring physical enrichment steps, thereby improving sensitivity while avoiding the time loss associated with enrichment procedures.
Solution Approach 2:
The iterative MS/MS acquisition maintains continuous useful action by systematically cycling through precursor selection and exclusion without interruption. This continuous iterative process efficiently accumulates exclusion data and improves detection sensitivity throughout the run, eliminating the need for separate enrichment steps and reducing total analysis time.
3Measurement precision
If automated precursor ion exclusion (PIE) acquisition is implemented, then low-abundance HCP identification is enhanced, but method complexity increases
Solution Approach 1:
The system performs self-service by automatically generating and updating the exclusion set based on its own mass spectrum data without external intervention. The automated PIE acquisition methodology uses built-in algorithms to identify, select, and exclude precursors iteratively, enhancing low-abundance HCP identification while managing complexity through self-contained automation rather than requiring complex external sample preparation or multiple instruments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
HCP-AIMS achieves deeper and more unbiased HCP identification compared to traditional data-dependent acquisition methods, with a detection limit of about 10 ppm or lower, and is suitable for high-throughput analysis, ensuring the quality and safety of therapeutic protein products.
Implementation Method 1
subjecting the sample to a chromatography column to obtain a chromatographic elution peak
Implementation Method 2
obtaining a mass spectrum scan; selecting a plurality of precursor ions from the acquired mass spectrum scan
Implementation Method 3
performing a tandem mass spectrometry analysis by performing a data-dependent acquisition cycle across the chromatographic elution peak
Data Source
AI summary
The present disclosure generally pertains to methods of identifying and quantitating host cell proteins (HCPs) in therapeutic protein development. In particular, the present invention generally pertains to methods of liquid chromatography-tandem mass spectrometry (LC-MS/MS) for unbiased identification and sensitive quantitation of HCPs in therapeutic protein development.